These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 22234776

  • 21. Pancreatic mass caused by Mycobacterium tuberculosis with reduced drug sensitivity.
    Small G, Wilks D.
    J Infect; 2001 Apr; 42(3):201-2. PubMed ID: 11545552
    [Abstract] [Full Text] [Related]

  • 22. [Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].
    Utkin VV.
    Probl Tuberk; 1978 Oct; (10):23-8. PubMed ID: 714901
    [No Abstract] [Full Text] [Related]

  • 23. [Therapy of tuberculosis in the adult].
    Schrappe M, Wassermann K, Kroegel C.
    Med Klin (Munich); 1995 Apr 15; 90(4):229-30. PubMed ID: 7776936
    [No Abstract] [Full Text] [Related]

  • 24. Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?
    Long R, Scalcini M.
    Int J Tuberc Lung Dis; 1999 Sep 15; 3(9):747-8. PubMed ID: 10488879
    [No Abstract] [Full Text] [Related]

  • 25. [Short-course treatment of pulmonary tuberculosis: comparison with a classical standard regimen].
    Bouslama A, Hedhiri H, Marzouki M, Jerray M, Djenayah F.
    Bull Int Union Tuberc; 1985 Sep 15; 60(1-2):29-30. PubMed ID: 4074969
    [No Abstract] [Full Text] [Related]

  • 26. [Short-course chemotherapy of tuberculosis with pyrazinamide].
    Asai S, Futsuki Y, Tomari S, Araki J.
    Nihon Rinsho; 1998 Dec 15; 56(12):3087-90. PubMed ID: 9883615
    [Abstract] [Full Text] [Related]

  • 27. [Isoprodian in combination with ethambutol and rifampicin in the treatment of tuberculosis (author's transl)].
    Hoose C.
    Prax Pneumol; 1975 Sep 15; 29(9):517-9. PubMed ID: 1208336
    [No Abstract] [Full Text] [Related]

  • 28. [Advances and principles in tuberculostatic therapy].
    Bethge H.
    Internist (Berl); 1971 Aug 15; 12(8):328-31. PubMed ID: 4328130
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
    Reves R, Heilig CM, Tapy JM, Bozeman L, Kyle RP, Hamilton CD, Bock N, Narita M, Wing D, Hershfield E, Goldberg SV, Tuberculosis Trials Consortium.
    Int J Tuberc Lung Dis; 2014 May 15; 18(5):571-80. PubMed ID: 24903795
    [Abstract] [Full Text] [Related]

  • 31. Mediastina Tuberculosis mass in a three-month-old boy.
    Boussetta K, Tinsa F, Ghaffari H, Brini I, Aloui N, Jaubert F, Bousnina S.
    Tunis Med; 2010 Aug 15; 88(8):602-4. PubMed ID: 20711969
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children.
    Graham SM, Grzemska M, Gie RP.
    Int J Tuberc Lung Dis; 2015 Dec 15; 19 Suppl 1():3-8. PubMed ID: 26564534
    [Abstract] [Full Text] [Related]

  • 35. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep 15; 49(4):327-45. PubMed ID: 8000420
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M, Bek E.
    Pneumonol Pol; 1980 Jul 15; 48(7):469-79. PubMed ID: 7433146
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.